0001799850false0001799850us-gaap:WarrantMember2022-05-252022-05-250001799850us-gaap:CommonStockMember2022-05-252022-05-2500017998502022-05-252022-05-25

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 25, 2022

 

 

Renovacor, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-39271

83-3169838

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

201 Broadway, Suite 310

 

Cambridge, Massachusetts

 

02139

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (610) 424-2650

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.0001 per share

 

RCOR

 

NYSE American LLC

Warrants to purchase one share of common stock at an exercise price of $11.50

 

RCOR.WS

 

NYSE American LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On May 25, 2022, Renovacor, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). The following is a brief description of the final voting results for each of the proposals submitted to a vote of the stockholders at the Annual Meeting.

 

Proposal 1 – Election of Class I Directors. Each of Jonas Grossman, Gbola Amusa and Edward J. Benz, Jr. were elected to the Board of Directors as Class I directors to serve until the Company’s 2025 Annual Meeting of Stockholders and until their successors, if any, are elected or appointed, or their earlier death, resignation, retirement, disqualification or removal as follows:

 

Name

 

For

 

Withheld

 

Broker Non-Votes

Jonas Grossman

 

8,359,979

 

1,289,156

 

803,692

Gbola Amusa

 

8,376,839

 

1,272,296

 

803,692

Edward J. Benz, Jr.

 

8,387,669

 

1,261,466

 

803,692

 

Proposal 2 – Ratification of Independent Registered Public Accountants. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2022 fiscal year was ratified, as follows:

 

For

 

Against

 

Abstentions

 

Broker Non-Votes

10,451,203

 

121

 

1,503

 

 

 


 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

RENOVACOR, INC.

 

 

 

 

Date:

May 26, 2022

By:

/s/ Magdalene Cook, M.D.

 

 

 

Magdalene Cook, M.D.

 

 

 

President, Chief Executive Officer and Director

 


Chardan Healthcare Acqui... (AMEX:CHAQ)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024 Plus de graphiques de la Bourse Chardan Healthcare Acqui...
Chardan Healthcare Acqui... (AMEX:CHAQ)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024 Plus de graphiques de la Bourse Chardan Healthcare Acqui...